Rise Advisors, LLC Roivant Sciences Ltd. Transaction History
Rise Advisors, LLC
- $220 Million
- Q1 2025
A detailed history of Rise Advisors, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Rise Advisors, LLC holds 1,242 shares of ROIV stock, worth $13,463. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,242Holding current value
$13,463% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
331Shares Held
496MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$713 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$670 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$499 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$442 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$389 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.64B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...